home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  June 17, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 462 active entries

ATG:biosynthetics GmbH

Weberstr. 40
79249 Merzhausen

Phone: +49 (0) 761/ 8889424
Fax: +49 (0) 761/ 8889425

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


ATG:biosynthetics is a synthetic biology and molecular biotech company located in Merzhausen near Freiburg/ Germany.

Mammalian display system tANCHOR for exposing antigens on the cell surface for direct immunization from cell culture expressing the antigene. Protein-Protein interaction experiments are feasible:

VITAGO! SARS-CoV2 ACE2 - RBD binding assay indicating neutralizing antibodies in case the ACE2-RBD interaction is prevented.Selective for alpha, beta, gamma, delta and lambda RBD variants !

Investors are welcome for financing the market entry.

We are experts in combinatorial gene design and multi-gene expression. We offer multi-gene and multi-peptide expression products and services for R&D:

  • Multi-protein recombineering and expression systems for E.coli, insect and mammalian cells (flexiTec)
  • Tailor-made expression systems for other (micro)organisms through our ToggleTec systems
  • Multi-peptide library design tool as well as multi-peptide library construction and expression system (PepID)
  • Synthetic bioinformatics for complex gene design/optimization projects, e.g. Gene intelligence solution EvoMAG for multi-parametric gene / gene cluster design and optimization in diverse target organisms (metabolic engineering, etc.)
  • Gene synthesis of individual genes and gene clusters
  • Synthetic biology projecting and consulting from design to (multi-gene) expression strategy

ATG is also looking for strategic partnerships and outsourcing projects that aim at developing and marketing high-potential applications, e.g. DNA- and protein based vaccines.

Selected Categories:
Product Company   Service Company
- General
- Research
- Research
- General
- Research
- Strategic
- Services

Last update of this entry: September 28, 2021

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.